Ashish Masurekar
YOU?
Author Swipe
View article: Activity and toxicity of intramuscular 1000 <scp>iu</scp>/m<sup>2</sup> polyethylene glycol‐<i>E. coli</i><scp>L‐asparaginase</scp> in the <scp>UKALL</scp> 2003 and <scp>UKALL</scp> 2011 clinical trials
Activity and toxicity of intramuscular 1000 <span>iu</span>/m<sup>2</sup> polyethylene glycol‐<i>E. coli</i><span>L‐asparaginase</span> in the <span>UKALL</span> 2003 and <span>UKALL</span> 2011 clinical trials Open
Summary In successive UK clinical trials (UKALL 2003, UKALL 2011) for paediatric acute lymphoblastic leukaemia (ALL), polyethylene glycol‐conjugated E. coli L‐asparaginase (PEG‐EcASNase) 1000 iu/m 2 was administered intramuscularly with ri…
View article: SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells
SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells Open
B cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most frequent type of cancer in children. Despite progresses in curative treatment, intensive chemotherapy regimens still cause life threatening complications. A better underst…
View article: Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia
Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia Open
Despite the high cure rates in childhood acute lymphoblastic leukemia (ALL), relapsed ALL remains a significant clinical problem. Genetic heterogeneity does not adequately explain variations in response to therapy. The chemoprotective tumo…